The hypertension advantage and natural selection: Since type 2 diabetes associates with co-morbidities and premature death, why have the genetic variants remained in the human genome?
- 1 August 2019
- journal article
- research article
- Published by Elsevier in Medical Hypotheses
- Vol. 129, 109237
Abstract
No abstract availableKeywords
Funding Information
- Michigan State University
This publication has 75 references indexed in Scilit:
- The genetics of type 2 diabetes: what have we learned from GWAS?Annals of the New York Academy of Sciences, 2010
- Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: ‘establishing normal and reference values’European Heart Journal, 2010
- Cardiovascular Disease in Type 2 Diabetes From Population to Man to MechanismsDiabetes Care, 2010
- A Genome-Wide Association Study of Type 2 Diabetes in Finns Detects Multiple Susceptibility VariantsScience, 2007
- Determinants of Maximal Oxygen Transport and UtilizationAnnual Review of Physiology, 1996
- Effect of athletic training on heart rate variabilityAmerican Heart Journal, 1994
- Common West African HLA antigens are associated with protection from severe malariaNature, 1991
- The effects of daily exercise on susceptibility to sudden cardiac death.Circulation, 1984
- The rate-pressure product as an index of myocardial oxygen consumption during exercise in patients with angina pectoris.Circulation, 1978
- Noninvasive evaluation of ventricular hypertrophy in professional athletes.Circulation, 1976